ciambra
menarini international operations luxembourg s.a. - hemipentahidrato de pemetrexed disodium - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra é indicado como monoterapia para o tratamento de manutenção da localmente avançado ou metastático de células não-pequenas de câncer de pulmão diferente predominantemente de células escamosas de histologia em pacientes cuja doença não avançou imediatamente seguinte platina baseado em quimioterapia. ciambra é indicado como monoterapia para a segunda linha de tratamento de pacientes com localmente avançado ou metastático de células não-pequenas de câncer de pulmão diferente predominantemente de células escamosas de histologia.
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
cloridrato de gencitabina
zydus nikkho farmacÊutica ltda - cloridrato de gencitabina - antineoplasico
emtaz
sun farmacÊutica do brasil ltda - cloridrato de gencitabina - antineoplasico
evozar
farmarin industria e comercio ltda - cloridrato de gencitabina - antineoplasico
gcib
cristÁlia produtos quÍmicos farmacÊuticos ltda. - cloridrato de gencitabina - antineoplasico
gemzar
eli lilly do brasil ltda - cloridrato de gencitabina - antineoplasico
genabyx
accord farmacÊutica ltda - cloridrato de gencitabina - antineoplasico
gencix
laboratÓrio quÍmico farmacÊutico bergamo ltda - cloridrato de gencitabina - antineoplasico
genlibbs
libbs farmacÊutica ltda - cloridrato de gencitabina - antineoplasico